Concepedia

Toshinobu Hayashi

TH

Statistics

Publications

17

Citations

437

H-Index

13

Active since

1987

Affiliations

National Hospital Organization Kyushu Cancer Center(Current)

Fukuoka University

Japanese Foundation For Cancer Research

Shikoku Cancer Center

Osaka City General Hospital

Toshinobu Hayashi is an author at National Hospital Organization Kyushu Cancer Center specializing in medicine, oncology, and cancer research.

ORCID

Top concepts

Publications per year

1987–2021

17

Publications

17

Randomized, double-blind, phase III trial of palonosetron versus granisetron in the triplet regimen for preventing chemotherapy-induced nausea and vomiting after highly emetogenic chemotherapy: TRIPLE study

K. Suzuki, Takeharu Yamanaka, Hiroki Hashimoto et al. · Annals of Oncology · 2016 · 97 citations · Full text

, , +6

Rhabdomyolysis secondary to lovastatin therapy

Anthony Manoukian, N.V. Bhagavan, Toshinobu Hayashi et al. · Clinical Chemistry · 1990 · 57 citations · Full text

A Nationwide, Multicenter Registry Study of Antiemesis for Carboplatin-Based Chemotherapy-Induced Nausea and Vomiting in Japan

Hirotoshi Iihara, Mototsugu Shimokawa, Toshinobu Hayashi et al. · The Oncologist · 2019 · 33 citations · Full text

Chemotherapy-induced nausea and vomiting (CINV) with carboplatin plus pemetrexed or carboplatin plus paclitaxel in patients with lung cancer: a propensity score-matched analysis

Toshinobu Hayashi, Mototsugu Shimokawa, Koichi Matsuo et al. · BMC Cancer · 2021 · 28 citations · Full text

Influence of ABCB1 and ABCG2 polymorphisms on the antiemetic efficacy in patients with cancer receiving cisplatin-based chemotherapy: a TRIPLE pharmacogenomics study

Daiki Tsuji, Mari Yokoi, Kenichi Suzuki et al. · The Pharmacogenomics Journal · 2016 · 25 citations

, , +10

1–5 of 17